Exhibit
31.2





CERTIFICATIONS





I,
Sanding Tao, certify that:





1. I have reviewed this report on Form
10-KSB, as amended, for the year ended December 31, 2007 of Huifeng
Bio-Pharmaceutical Technology, Inc.;




2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;




3. Based on my knowledge, the financial
statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of
operations and cash flows
of the registrant as of, and for, the periods presented in this
report;




4. The registrant's other certifying
officers and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f) for the registrant and have:




(a) designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being
prepared;




(b) designed such internal control over
financial reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance regarding the
reliability of financialreporting and the preparation of financial statements, for external purposes in
accordance with generally accepted accounting principles;




(c) evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this
reportour conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation;
and




(d) disclosed in this report any change
in the registrant's internal control over financial reporting that occurred during the
registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter
in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over financial reporting;
and




5. The registrant's other certifying
officer and I have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrant's auditors and the audit
committee of the registrant's board of directors (or persons
performing the equivalent functions):




(a) all significant deficiencies and
material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the
registrant's ability to
record, process, summarize and report financial information;
and




(b) any fraud, whether or not material,
that involves management or other employees who have a significant role in the
registrant's internal control over financial reporting.







Date:January20,
2009                                                                By:/s/Sanding
Tao


Sanding Tao, Chief Financial
Officer